High immunoproteasome concentration in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of longer OS.
Adv Med Sci
; 66(1): 21-27, 2021 Mar.
Article
em En
| MEDLINE
| ID: mdl-33246214
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Biomarcadores
/
Proteoma
/
Bortezomib
/
Mieloma Múltiplo
/
Antineoplásicos
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article